Abstract
This paper briefly reviews the characteristics of photoaged skin, and the mechanisms involved in skin photoaging and repair. Sun-exposed skin shows superficial changes, such as wrinkles, sagging, telangiectasis and pigmentary changes, pathological changes such as neoplasia, and also many internal changes in the structure and function of epidermis, basement membrane, and dermis. These changes (so-called photoaging) are predominantly due to the ultraviolet (UV) component of sunlight.
Enzymes such as matrix metalloproteinases (MMPs), urinary plasminogen activator (uPA)/plasmin, and heparanase are increased in epidermis of UV-irradiated skin. These enzymes degrade epidermal basement membrane (BM) components, dermal collagen fibers, and elastic fibers. The BM, which is located at the dermal-epidermal junction, controls dermal-epidermal signaling and is essential for maintaining a healthy epidermis and dermis. Repeated BM damage occurs in sun-exposed skin compared to unexposed skin, leading to epidermal and dermal deterioration and accelerated skin aging. UV-induced skin damage is cumulative and leads to premature aging of skin. However, appropriate daily skin treatment may ameliorate photoaging by inhibiting processes causing damage and enhancing repair processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tagami H. Functional characteristics of the stratum corneum in photoaged skin in comparison with those found in intrinsic aging. Arch Dermatol Res. 2008;300 Suppl 1:S1–6.
Lavker RM. Structural alterations in exposed and unexposed aged skin. J Invest Dermatol. 1979;73(1):59–66.
Kligman AM, et al. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2):836–59.
Ryan MC, et al. The functions of laminins: lessons from in vivo studies. Matrix Biol. 1996;15(6):369–81.
Bohnert A, et al. Epithelial-mesenchymal interactions control basement membrane production and differentiation in cultured and transplanted mouse keratinocytes. Cell Tissue Res. 1986;244(2):413–29.
Watt FM. Selective migration of terminally differentiating cells from the basal layer of cultured human epidermis. J Cell Biol. 1984;98(1):16–21.
Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci U S A. 1987;84(8):2302–6.
Hirai Y, et al. Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell. 1992;69(3):471–81.
Inoue S. Ultrastructure of basement membranes. Int Rev Cytol. 1989;117:57–98.
Amano S, et al. Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. J Biol Chem. 2000;275(30):22728–35.
Goldfinger LE, Stack MS, Jones JC. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol. 1998;141(1):255–65.
Koshikawa N, et al. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain. J Biol Chem. 2005;280(1):88–93.
Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol. 1995;7(5):728–35.
Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis. 1996;2(1):70–6.
Fassina G, et al. Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis. 2000;18(2):111–20.
Goldberg GI, et al. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A. 1989;86(21):8207–11.
Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta. 1985;823(1):35–65.
Morioka S, Jensen PJ, Lazarus GS. Human epidermal plasminogen activator. Characterization, localization, and modulation. Exp Cell Res. 1985;161(2):364–72.
Marschall C, et al. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression. J Invest Dermatol. 1999;113(1):69–76.
Plow EF, et al. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol. 1986;103(6 Pt 1):2411–20.
Katsuta Y, et al. Urokinase-type plasminogen activator is activated in stratum corneum after barrier disruption. J Dermatol Sci. 2003;32(1):55–7.
Denda M, et al. Trans-4-(Aminomethyl)cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J Invest Dermatol. 1997;109(1):84–90.
Nakajima M, et al. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem. 1984;259(4):2283–90.
Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta. 2001;1471(3):M99–108.
Bernard D, et al. Purification and characterization of the endoglycosidase heparanase 1 from human plantar stratum corneum: a key enzyme in epidermal physiology? J Invest Dermatol. 2001;117(5):1266–73.
Friedl A, et al. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. Am J Pathol. 1997;150(4):1443–55.
Fuki II, Iozzo RV, Williams KJ. Perlecan heparan sulfate proteoglycan. A novel receptor that mediates a distinct pathway for ligand catabolism. J Biol Chem. 2000;275(40):31554.
Patel VN, et al. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development. 2007;134(23):4177–86.
Sebollela A, et al. Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization. J Biol Chem. 2005;280(36):31949–56.
Perrimon N, Bernfield M. Specificities of heparan sulphate proteoglycans in developmental processes. Nature. 2000;404(6779):725–8.
Vlodavsky I, et al. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 1996;15(2):177–86.
Bell E, et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 1981;211(4486):1052–4.
Amano S, et al. Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation. Exp Cell Res. 2001;271(2):249–62.
Tsunenaga M, et al. Laminin 5 can promote assembly of the lamina densa in the skin equivalent model. Matrix Biol. 1998;17(8–9):603–13.
Sarret Y, et al. Constitutive synthesis of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by type I collagen and decreased by type IV collagen matrices. J Invest Dermatol. 1992;99(6):836–41.
Sudbeck BD, et al. Collagen-stimulated induction of keratinocyte collagenase is mediated via tyrosine kinase and protein kinase C activities. J Biol Chem. 1994;269(47):30022–9.
Koivukangas V, et al. UV irradiation induces the expression of gelatinases in human skin in vivo. Acta Derm Venereol. 1994;74(4):279–82.
Fisher GJ, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379(6563):335–9.
Inomata S, et al. Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol. 2003;120(1):128–34.
Amano S, et al. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process. Br J Dermatol. 2005;153 Suppl 2:37–46.
Miralles F, et al. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element. Mol Cell Biol. 1998;18(8):4537–47.
Scharffetter K, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res. 1991;283(8):506–11.
Ogura Y, et al. Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. Br J Dermatol. 2008;159(1):49–60.
Fleischmajer R, et al. Skin fibroblasts are the only source of nidogen during early basal lamina formation in vitro. J Invest Dermatol. 1995;105(4):597–601.
Iriyama S, et al. Influence of heparan sulfate chains in proteoglycan at the dermal-epidermal junction on epidermal homeostasis. Exp Dermatol 2011;20(10):810–4.
Iriyama S, et al. Activation of heparanase by ultraviolet B irradiation leads to functional loss of basement membrane at the dermal-epidermal junction in human skin. Arch Dermatol Res. 2011;303(4): 53–61.
Iriyama S, et al. Key role of heparan sulfate chains in assembly of anchoring complex at the dermal-epidermal junction. Exp Dermatol. 2011;20(11):953–5.
Behrens DT, et al. The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem. 2012;287(22):18700–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Amano, S. (2017). Possible Involvement of Basement Membrane Damage by Matrix Metalloproteinases, Serine Proteinases, and Heparanase in Skin Aging Process. In: Farage, M., Miller, K., Maibach, H. (eds) Textbook of Aging Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47398-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-47398-6_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47397-9
Online ISBN: 978-3-662-47398-6
eBook Packages: MedicineReference Module Medicine